detect
chanc
follow
zair
ebolaviru
copiesml
plasma
sudan
ebolaviru
maleo
detect
chanc
follow
zair
ebolaviru
copiesml
plasma
sudan
ebolaviru
maleo
copiesml
sudan
ebolaviru
gulu
copiesml
cote
divoir
ebolaviru
copiesml
reston
ebolaviru
copiesml
lake
victoria
marburgviru
musok
copiesml
lake
victoria
marburgviru
ravn
copiesml
assay
facilit
reliabl
detect
exclus
screen
filoviru
infect
famili
filovirida
order
mononegaviral
contain
genera
pathogen
virus
ebolaviru
ebov
marburgviru
marv
ebov
compris
speci
zair
ebolaviru
zebov
sudan
ebolaviru
sebov
cote
divoir
ebolaviru
ciebov
reston
ebolaviru
rebov
agent
human
diseas
filovirus
usual
encount
context
outbreak
africa
import
case
filoviru
infect
rare
nevertheless
potenti
import
filovirus
return
travel
frequent
concern
symptom
similar
diseasesfor
exampl
malariaand
risk
nosocomi
filoviru
transmiss
although
confirm
outbreak
situat
case
definit
partial
substitut
laboratori
test
suspect
case
import
laboratori
diagnosi
alway
requir
sever
ill
patient
test
number
hemorrhag
fever
virus
eg
ebov
marv
lassa
viru
yellow
fever
viru
crimeancongo
hemorrhag
fever
viru
short
time
high
reliabl
exclud
result
issu
similar
scenario
aris
screen
sick
nonhuman
primat
monitor
worker
laboratori
accid
context
suspect
bioterror
reliabl
methodolog
establish
appropri
viru
materi
avail
howev
viru
strain
clinic
sampl
limit
subject
biosecur
regul
polymeras
chain
reaction
pcr
design
often
reli
theoret
genom
inform
filovirus
incomplet
public
databas
recent
extern
qualityassur
studi
demonstr
overal
level
diag
nostic
pcr
profici
filovirus
low
realtim
pcr
especi
readytous
test
kit
could
improv
situat
reagent
avail
industri
within
network
support
european
union
european
biosafeti
level
laboratori
togeth
biotechnolog
compani
qiagen
develop
diagnost
realtim
pcr
assay
filovirus
strain
store
european
laboratori
collat
sequenc
assay
react
filovirus
design
assay
evalu
repres
filovirus
test
convert
prototyp
test
kit
present
inhous
version
test
well
comprehens
evalu
data
prototyp
kit
filoviru
strain
grown
vero
cell
condit
viru
titer
supernat
determin
immunolog
focu
assay
use
ebovor
marvspecif
antibodi
part
l
gene
zebov
eckron
initi
assay
design
use
new
sequenc
publish
data
zebov
genbank
access
mayinga
sebov
maleo
rebov
reston
pennysylvania
marv
popp
mvvirpr
ozolin
musok
mrvmbgl
inspect
align
rel
conserv
bind
site
primer
probe
identifi
posit
select
appropri
oligonucleotid
guid
melt
point
fold
characterist
crosshybrid
properti
determin
primer
express
packag
appli
biosystem
primer
end
avoid
third
codon
posit
wobbl
posit
primer
avoid
guarante
reliabl
resynthesi
primer
necessari
viru
sequenc
heterogen
compens
mix
defin
oligonucleotid
stabl
nonwatsoncrick
base
pair
g
strictli
adjust
quantifi
vitro
transcrib
rna
gener
clone
reversetranscript
rt
pcr
target
region
togeth
suffici
flank
sequenc
plasmid
insert
togeth
promot
sequenc
amplifi
plasmidspecif
primer
transcrib
vitro
rna
use
megascript
kit
ambion
dnase
digest
affin
purif
transcript
quantifi
photomet
use
quantif
standard
monitor
sensit
singl
reaction
assay
intern
competit
control
construct
consist
copi
target
rna
sequenc
contain
mutagen
probe
bind
site
could
detect
altern
probe
label
specif
report
dye
control
gener
overlapextens
pcr
zebov
plasmid
describ
elsewher
use
mutagen
primer
atcgttcgttgagcgattagcagtgaacatgccacagttagagggagt
ctgctaatcgctcaacgaacgattgatgcttgatgcaataagctttctt
mutat
construct
clone
back
transcrib
rna
inhous
version
diagnost
assay
base
qiagen
rtpcr
kit
use
total
reaction
volum
includ
ml
rna
qiagen
viral
rna
mini
kit
reaction
supplement
ngml
bovin
serum
albumin
mmoll
dntp
primer
use
follow
fluoresc
measur
cycl
step
viru
signal
read
wavelength
intern
control
signal
read
wavelength
l
gene
filovirus
select
pair
primer
target
gene
filoa
filob
use
success
number
previou
studi
seven
new
sequenc
target
region
gener
genbank
access
sebov
gulu
zebov
gabon
zebov
gabon
zebov
gabon
marv
ravn
ciebov
use
assay
design
togeth
sequenc
avail
time
initi
attempt
made
keep
publish
filoafilob
primer
posit
howev
filoa
appropri
rebov
ciebov
shift
downstream
posit
mrna
sens
mix
primer
use
appropri
bind
site
also
benefici
obtain
short
amplif
fragment
requir
probebas
realtim
rtpcr
primer
filob
could
kept
supplement
addit
oligonucleotid
specif
marv
three
detect
probe
formul
separ
zebovrebov
sebovciebov
marv
shown
figur
inosinecontain
probe
possibl
compens
mani
nucleotid
mismatch
maxim
observ
ebov
without
lose
signal
intens
figur
marv
adapt
necessari
need
chang
assay
design
view
recent
publish
filoviru
sequenc
figur
provid
summari
sequenc
divers
observ
oligonucleotid
bind
site
updat
octob
sequenc
outbreak
marv
infect
uig
angola
yet
publish
oligonucleotid
design
studi
compat
sequenc
confirm
us
public
mix
detect
probe
ebov
marv
reaction
led
slight
decreas
plateau
fluoresc
signal
oppos
seen
separ
detect
howev
affect
overal
assay
sensit
shown
figur
rna
test
strain
detect
high
sensit
copiesassay
primer
probe
combin
test
genom
rna
extract
viru
prepar
amount
pfu
zebov
sebov
marv
could
detect
per
assay
assay
supplement
competit
intern
control
optim
work
concentr
copiesassay
determin
crosstitr
constant
low
amount
target
rna
figur
limit
detect
inhous
assay
determin
probit
analys
describ
elsewher
experi
use
quantifi
vitro
transcrib
rna
sebov
gulu
marv
musok
sebov
detect
chanc
plasma
contain
least
rna
copiesml
confid
interv
ci
copiesml
correspond
number
marv
musok
copiesml
ci
copiesml
specif
filovirus
confirm
use
panel
heterolog
virus
assay
crossreact
rna
extract
undilut
cell
cultur
supernat
lassa
assay
transform
prototyp
artu
filoviru
lc
rtpcr
kit
use
proprietari
technolog
preserv
oligonucleotid
describ
proprietari
noncompetit
intern
control
rna
includ
instead
competit
intern
control
use
inhous
version
sensit
evalu
plaquequantifi
viru
stock
materi
shown
figur
well
sampl
panel
recent
profici
test
studi
filoviru
sampl
studi
correctli
detect
rna
quantif
result
show
log
deviat
predetermin
data
clinic
specimen
avail
patient
serum
sampl
outbreak
sebov
infect
uganda
buccal
swab
outbreak
zebov
infect
gabon
test
materi
rtpcr
describ
elsewher
readili
detect
assay
intraand
interassay
variabl
also
determin
twenti
parallel
determin
run
sampl
contain
copiesreact
yield
intraassay
coeffici
variat
base
averag
cross
point
valu
sampl
test
independ
run
interassay
coeffici
variat
seen
averag
cross
point
valu
precis
limit
detect
determin
collect
viru
strain
repres
spectrum
genet
divers
oligonucleotid
bind
site
result
probit
analys
summar
figur
recent
studi
rare
pathogen
sever
acut
respiratori
syndrom
sar
coronaviru
orthopox
virus
west
nile
viru
shown
avail
readymad
test
kit
posit
influenc
laboratori
perform
feasibl
develop
kit
close
collabor
industri
demonstr
connect
sar
outbreak
test
kit
made
avail
epidem
main
purpos
present
studi
design
similar
kit
filovirus
preliminari
work
done
academ
government
institut
lower
financi
entri
threshold
compani
collabor
network
partner
kit
could
produc
accord
high
qualiti
standard
featur
compar
commerci
diagnost
pcr
system
eg
hepat
c
viru
hepat
b
viru
first
probebas
assay
compat
known
filoviru
speci
intern
control
monitor
sensit
everi
singl
reaction
analyt
properti
evalu
accord
industryapprov
standard
probit
analysi
broad
rang
filoviru
strain
intraand
interassay
variabl
analysi
specif
test
exhaust
panel
virus
caus
relat
clinic
manifest
data
ensur
wide
accept
assay
standard
test
europ
could
also
serv
entri
point
product
vitro
diagnost
procedur
irrespect
whether
assay
use
inhous
version
reagent
kit
never
guarante
pcr
assay
detect
unknown
filoviru
strain
may
emerg
futur
diagnost
filoviru
infect
alway
base
whole
rang
diagnost
test
includ
pcr
antigen
test
antibodi
detect
viru
cultur
moreov
new
technic
develop
novel
viru
strain
impos
continu
work
molecular
assay
present
studi
shown
work
possibl
collabor
exchang
viru
materi
view
expand
restrict
context
biosecur
care
taken
indispens
collabor
still
possibl
futur
